Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CGNX - US1924221039 - Common Stock

37.95 USD
-0.15 (-0.39%)
Last: 12/1/2025, 8:00:00 PM
37.9 USD
-0.05 (-0.13%)
After Hours: 12/1/2025, 8:00:00 PM
Fundamental Rating

7

Taking everything into account, CGNX scores 7 out of 10 in our fundamental rating. CGNX was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. CGNX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CGNX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CGNX had positive earnings in the past year.
In the past year CGNX had a positive cash flow from operations.
CGNX had positive earnings in each of the past 5 years.
CGNX had a positive operating cash flow in each of the past 5 years.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

The Return On Assets of CGNX (5.50%) is better than 72.80% of its industry peers.
CGNX's Return On Equity of 7.39% is fine compared to the rest of the industry. CGNX outperforms 64.00% of its industry peers.
With a decent Return On Invested Capital value of 7.09%, CGNX is doing good in the industry, outperforming 71.20% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CGNX is in line with the industry average of 9.09%.
Industry RankSector Rank
ROA 5.5%
ROE 7.39%
ROIC 7.09%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CGNX has a Profit Margin of 11.33%. This is amongst the best in the industry. CGNX outperforms 85.60% of its industry peers.
In the last couple of years the Profit Margin of CGNX has declined.
Looking at the Operating Margin, with a value of 16.27%, CGNX belongs to the top of the industry, outperforming 90.40% of the companies in the same industry.
In the last couple of years the Operating Margin of CGNX has declined.
Looking at the Gross Margin, with a value of 67.65%, CGNX belongs to the top of the industry, outperforming 96.80% of the companies in the same industry.
In the last couple of years the Gross Margin of CGNX has declined.
Industry RankSector Rank
OM 16.27%
PM (TTM) 11.33%
GM 67.65%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

CGNX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CGNX has been reduced compared to 1 year ago.
Compared to 5 years ago, CGNX has less shares outstanding
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 8.77 indicates that CGNX is not in any danger for bankruptcy at the moment.
CGNX has a better Altman-Z score (8.77) than 84.80% of its industry peers.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.77
ROIC/WACC0.8
WACC8.87%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CGNX has a Current Ratio of 3.96. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
CGNX's Current ratio of 3.96 is fine compared to the rest of the industry. CGNX outperforms 72.80% of its industry peers.
A Quick Ratio of 3.11 indicates that CGNX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.11, CGNX is doing good in the industry, outperforming 77.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.96
Quick Ratio 3.11
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.62% over the past year.
The Earnings Per Share has been decreasing by -2.03% on average over the past years.
Looking at the last year, CGNX shows a quite strong growth in Revenue. The Revenue has grown by 10.23% in the last year.
CGNX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.74% yearly.
EPS 1Y (TTM)44.62%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%65%
Revenue 1Y (TTM)10.23%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%17.96%

3.2 Future

Based on estimates for the next years, CGNX will show a very strong growth in Earnings Per Share. The EPS will grow by 30.44% on average per year.
CGNX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.52% yearly.
EPS Next Y31.11%
EPS Next 2Y25.7%
EPS Next 3Y23.02%
EPS Next 5Y30.44%
Revenue Next Year7.81%
Revenue Next 2Y7.89%
Revenue Next 3Y8.29%
Revenue Next 5Y9.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

CGNX is valuated quite expensively with a Price/Earnings ratio of 40.37.
The rest of the industry has a similar Price/Earnings ratio as CGNX.
Compared to an average S&P500 Price/Earnings ratio of 26.11, CGNX is valued quite expensively.
With a Price/Forward Earnings ratio of 32.46, CGNX can be considered very expensive at the moment.
CGNX's Price/Forward Earnings is on the same level as the industry average.
CGNX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 36.21.
Industry RankSector Rank
PE 40.37
Fwd PE 32.46
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CGNX.
Based on the Price/Free Cash Flow ratio, CGNX is valued a bit cheaper than 69.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.75
EV/EBITDA 31.51
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CGNX may justify a higher PE ratio.
CGNX's earnings are expected to grow with 23.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.3
PEG (5Y)N/A
EPS Next 2Y25.7%
EPS Next 3Y23.02%

5

5. Dividend

5.1 Amount

CGNX has a yearly dividend return of 0.89%, which is pretty low.
CGNX's Dividend Yield is rather good when compared to the industry average which is at 2.35. CGNX pays more dividend than 84.00% of the companies in the same industry.
With a Dividend Yield of 0.89, CGNX pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.89%

5.2 History

The dividend of CGNX is nicely growing with an annual growth rate of 8.39%!
CGNX has paid a dividend for at least 10 years, which is a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

49.16% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
CGNX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.16%
EPS Next 2Y25.7%
EPS Next 3Y23.02%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (12/1/2025, 8:00:00 PM)

After market: 37.9 -0.05 (-0.13%)

37.95

-0.15 (-0.39%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners101.95%
Inst Owner Change1.74%
Ins Owners0.27%
Ins Owner Change-0.03%
Market Cap6.36B
Revenue(TTM)971.71M
Net Income(TTM)110.12M
Analysts75.86
Price Target49.19 (29.62%)
Short Float %2.5%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 0.89%
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP49.16%
Div Incr Years3
Div Non Decr Years3
Ex-Date11-13 2025-11-13 (0.085)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.79%
Min EPS beat(2)3.71%
Max EPS beat(2)11.87%
EPS beat(4)4
Avg EPS beat(4)15.13%
Min EPS beat(4)3.71%
Max EPS beat(4)26.05%
EPS beat(8)8
Avg EPS beat(8)16.02%
EPS beat(12)11
Avg EPS beat(12)15.02%
EPS beat(16)14
Avg EPS beat(16)16.54%
Revenue beat(2)1
Avg Revenue beat(2)1.36%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)3.51%
Revenue beat(4)2
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)3.51%
Revenue beat(8)4
Avg Revenue beat(8)0.74%
Revenue beat(12)6
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)0.94%
PT rev (1m)1.22%
PT rev (3m)4.05%
EPS NQ rev (1m)-0.54%
EPS NQ rev (3m)-1.37%
EPS NY rev (1m)3.16%
EPS NY rev (3m)3.9%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)0.21%
Revenue NY rev (1m)1.03%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 40.37
Fwd PE 32.46
P/S 6.55
P/FCF 29.75
P/OCF 28.65
P/B 4.27
P/tB 6.29
EV/EBITDA 31.51
EPS(TTM)0.94
EY2.48%
EPS(NY)1.17
Fwd EY3.08%
FCF(TTM)1.28
FCFY3.36%
OCF(TTM)1.32
OCFY3.49%
SpS5.8
BVpS8.89
TBVpS6.03
PEG (NY)1.3
PEG (5Y)N/A
Graham Number13.71
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 7.39%
ROCE 8.62%
ROIC 7.09%
ROICexc 8.48%
ROICexgc 12.33%
OM 16.27%
PM (TTM) 11.33%
GM 67.65%
FCFM 22%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexgc growth 3Y-25.69%
ROICexgc growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 26.24%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 117.19%
Profit Quality 194.14%
Current Ratio 3.96
Quick Ratio 3.11
Altman-Z 8.77
F-Score8
WACC8.87%
ROIC/WACC0.8
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)44.62%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%65%
EPS Next Y31.11%
EPS Next 2Y25.7%
EPS Next 3Y23.02%
EPS Next 5Y30.44%
Revenue 1Y (TTM)10.23%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%17.96%
Revenue Next Year7.81%
Revenue Next 2Y7.89%
Revenue Next 3Y8.29%
Revenue Next 5Y9.52%
EBIT growth 1Y67.86%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year53.61%
EBIT Next 3Y31.29%
EBIT Next 5Y22.1%
FCF growth 1Y47.96%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y34.8%
OCF growth 3Y-22%
OCF growth 5Y-10.06%

COGNEX CORP / CGNX FAQ

What is the fundamental rating for CGNX stock?

ChartMill assigns a fundamental rating of 7 / 10 to CGNX.


What is the valuation status of COGNEX CORP (CGNX) stock?

ChartMill assigns a valuation rating of 4 / 10 to COGNEX CORP (CGNX). This can be considered as Fairly Valued.


What is the profitability of CGNX stock?

COGNEX CORP (CGNX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for COGNEX CORP?

The Earnings per Share (EPS) of COGNEX CORP (CGNX) is expected to grow by 31.11% in the next year.


Can you provide the dividend sustainability for CGNX stock?

The dividend rating of COGNEX CORP (CGNX) is 5 / 10 and the dividend payout ratio is 49.16%.